By the end of March, Pfizer and Moderna expect to have provided the U.S. government with a total of 220 million vaccine doses, up sharply from the roughly 75 million shipped so far.
“We think we're at a very good spot.”That's not counting a third vaccine, from Johnson & Johnson, that's expected to get a green light from regulators soon.
AdLooking ahead to summer, Pfizer and Moderna expect to complete delivery of 300 million doses each, and J&J aims to provide an additional 100 million doses.
“The most pressing challenge now is the lack of supply of vaccine doses,” Rep. Diana DeGette, a Colorado Democrat, said as she opened the hearing.
AdNearly 14% of Americans have received at least an initial dose of the two-shot-regimen vaccines from Pfizer and Moderna.